<DOC>
	<DOC>NCT01531075</DOC>
	<brief_summary>The objective is to assess the efficacy of Hepatitis B Virus vaccination in a population of IBD patients treated with immunosuppressive medications.</brief_summary>
	<brief_title>Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male/female â‰¥ 18 years of age Evidence of IBD as diagnosed by clinical, laboratory imaging and endoscopic criteria. Treated with at least one immunosuppressive medication at the time of study initiation Provided written informed consent. Pregnant women Diagnosis of chronic viral hepatitis B Any major acute medical event in the 30 days prior to recruitment that necessitated hospitalization ( acute myocardial infarction, CVA, pulmonary emboli, sepsis, major trauma) Any other chronic inflammatory condition not related to IBD ( connective tissue disease, Chronic liver disease, COPD, poorly controlled diabetes mellitus) Active hematologic or oncologic diseases</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>HBV, Inflammatory bowel disease, immunosuppressor</keyword>
</DOC>